Word

Status

Dead

Status Code

606

Status Date

Monday, August 2, 2021

Serial Number

88493580

Mark Type

2000

Filing Date

Friday, June 28, 2019

Published for Opposition

Tuesday, May 5, 2020

Abandoned Date

Monday, August 2, 2021

Trademark Owner History

Navitor Pharmaceuticals, Inc. - Owner At Publication

Classifications

5 Pharmaceutical preparations and substances for the prevention, treatment and diagnosis of cancer, diabetes, and heart disease; pharmaceutical preparations and substances for the prevention, treatment and diagnosis of neurodegenerative diseases, namely, Alzheimer's disease, Parkinson's disease, and Huntington's disease; pharmaceutical preparations and substances for the prevention, treatment and diagnosis of immune disorders, namely, psoriasis, rheumatoid arthritis, lupus, Chron's disease, inflammatory bowel disease, and multiple sclerosis; pharmaceutical preparations and substances for the prevention, treatment and diagnosis of metabolic, endocrine, cardiovascular, oncological, gastrointestinal, musculoskeletal, mitochondrial, autoimmune, and neurological related diseases and disorders; pharmaceutical preparations and substances for the prevention, treatment and diagnosis of rare genetic diseases; pharmaceutical preparations and substances for the prevention, treatment and diagnosis of Leigh's syndrome, Friedrich's ataxia, lymphangioleiomyomatosis (LAM) and tuberous sclerosis; pharmaceutical preparations and substances for the prevention, treatment and diagnosis of obesity and obesity related diseases; pharmaceutical preparations and substances for the prevention, treatment and diagnosis of age-related diseases; pharmaceutical preparations and substances for modulating the catabolic or anabolic response to nutrients; pharmaceutical preparations and substances for the prevention, treatment and diagnosis of any disease related to muscle wasting diseases and conditions, including, cachexia, sarcopenia and muscle wasting due to prolonged immobilization; pharmaceutical agents affecting metabolism; pharmaceutical agents affecting caloric intake and absorption; nutraceuticals for use as dietary supplements; dietetic foods adapted for medical use; nutritional supplements containing amino acids; pharmaceutical preparations and substances for the modulation of appetite, namely, appetite suppressants and satiety inducers

The color(s) green and purple is/are claimed as a feature of the mark.
The mark consists of a spiral design composed of a green incomplete circle and purple gradient dots.

Trademark Events

Aug 2, 2021

Abandonment Notice E-Mailed - No Use Statement Filed

Aug 2, 2021

Abandonment - No Use Statement Filed

Dec 25, 2020

Notice Of Approval Of Extension Request E-Mailed

Dec 23, 2020

Extension 1 Granted

Dec 23, 2020

Extension 1 Filed

Dec 23, 2020

Teas Extension Received

Jun 30, 2020

Noa E-Mailed - Sou Required From Applicant

May 5, 2020

Official Gazette Publication Confirmation E-Mailed

May 5, 2020

Published For Opposition

Apr 15, 2020

Notification Of Notice Of Publication E-Mailed

Mar 26, 2020

Approved For Pub - Principal Register

Mar 26, 2020

Examiner's Amendment Entered

Mar 26, 2020

Notification Of Examiners Amendment E-Mailed

Mar 26, 2020

Examiners Amendment E-Mailed

Mar 26, 2020

Examiners Amendment -Written

Mar 19, 2020

Teas/Email Correspondence Entered

Mar 19, 2020

Correspondence Received In Law Office

Mar 19, 2020

Teas Response To Office Action Received

Sep 19, 2019

Notification Of Non-Final Action E-Mailed

Sep 19, 2019

Non-Final Action E-Mailed

Sep 19, 2019

Non-Final Action Written

Sep 18, 2019

Assigned To Examiner

Jul 10, 2019

Preliminary/Voluntary Amendment - Entered

Jul 10, 2019

Notice Of Design Search Code E-Mailed

Jul 9, 2019

New Application Office Supplied Data Entered In Tram

Jul 8, 2019

Assigned To Lie

Jul 2, 2019

Teas Voluntary Amendment Received

Jul 2, 2019

New Application Entered In Tram